NO20081481L - Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning - Google Patents

Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning

Info

Publication number
NO20081481L
NO20081481L NO20081481A NO20081481A NO20081481L NO 20081481 L NO20081481 L NO 20081481L NO 20081481 A NO20081481 A NO 20081481A NO 20081481 A NO20081481 A NO 20081481A NO 20081481 L NO20081481 L NO 20081481L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
controlled release
composition containing
containing carvedilol
carvedilol
Prior art date
Application number
NO20081481A
Other languages
English (en)
Norwegian (no)
Inventor
Pal Fekete
Zoltan Budavari
Agnes Bozso
Magdolna Leventiszne Huszar
Zoltanne Palfi
Palne Szentgroti
Erika Davidne Karacs
Aniko Turoczine Kuncze
Krisztina Abraham
Zsolt Zsigmond
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20081481L publication Critical patent/NO20081481L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20081481A 2005-08-26 2008-03-26 Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning NO20081481L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500803A HU227490B1 (en) 2005-08-26 2005-08-26 Sustained release pharmaceutical preparation containing carvedilol
PCT/HU2006/000068 WO2007023325A2 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol

Publications (1)

Publication Number Publication Date
NO20081481L true NO20081481L (no) 2008-05-19

Family

ID=89986232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081481A NO20081481L (no) 2005-08-26 2008-03-26 Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning

Country Status (11)

Country Link
EP (1) EP1928431B8 (de)
AT (1) ATE418969T1 (de)
DE (1) DE602006004610D1 (de)
DK (1) DK1928431T3 (de)
EA (1) EA013058B1 (de)
ES (1) ES2321980T3 (de)
HU (1) HU227490B1 (de)
NO (1) NO20081481L (de)
PL (1) PL1928431T3 (de)
PT (1) PT1928431E (de)
WO (1) WO2007023325A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
EP2037927B1 (de) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
MX2009002031A (es) 2006-08-25 2009-03-06 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo.
HU227881B1 (en) * 2007-02-23 2012-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Sustained release pharmaceutical preparation containing carvedilol
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
PL2187876T3 (pl) 2007-09-21 2013-01-31 Evonik Roehm Gmbh Farmaceutyczna kompozycja opioidowa o zależnym od pH kontrolowanym uwalnianiu z odpornością przed wpływem etanolu
WO2009047800A2 (en) * 2007-10-09 2009-04-16 Lupin Limited Oral controlled release composition of carvedilol
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN103099793B (zh) * 2013-02-06 2015-07-15 中国人民解放军第二军医大学 片剂及其制备方法
JP7336187B2 (ja) 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002065834A2 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems

Also Published As

Publication number Publication date
HU227490B1 (en) 2011-07-28
PL1928431T3 (pl) 2009-07-31
ES2321980T3 (es) 2009-06-15
EA200800666A1 (ru) 2008-06-30
HU0500803D0 (en) 2005-11-28
DK1928431T3 (da) 2009-04-20
ATE418969T1 (de) 2009-01-15
PT1928431E (pt) 2009-03-25
EP1928431B8 (de) 2009-04-08
EA013058B1 (ru) 2010-02-26
DE602006004610D1 (de) 2009-02-12
HUP0500803A2 (en) 2007-05-29
EP1928431B1 (de) 2008-12-31
WO2007023325A3 (en) 2007-06-28
WO2007023325A2 (en) 2007-03-01
EP1928431A2 (de) 2008-06-11
HUP0500803A3 (en) 2008-03-28

Similar Documents

Publication Publication Date Title
NO20081481L (no) Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning
WO2011063089A3 (en) Surface-modified adhesives
CL2009000550A1 (es) Metodo para mantener el estado de latencia de una semilla y evitar la germinacion de la misma que comprende revestir dicha semilla con una composicion que comprende particulas que contienen un material de nucleo, el cual comprende un material de cambio de fase.
MX339587B (es) Pelicula que se puede rotular con laser resistente al calor.
WO2008132045A3 (en) Substrates with biocidal coating
WO2010017558A3 (en) Composite material compositions and methods
EP2236283A4 (de) Glieder mit einem korrosionsbeständigen beschichtungsfilm, verfahren zu dessen herstellung und beschichtungszusammensetzung für dessen herstellung
BR112012013076A2 (pt) processo para revestir substratos cerâmicos, e, substrato cerâmico.
WO2008115890A3 (en) Mapk/erk kinase inhibitors
TWI370160B (en) Conductive polymer coating composition, method of preparing coating film using the conductive polymer coating composition, and coating film prepared using the method
DK2054502T3 (da) Nykonstrueret mikroorganisme, der producerer homo-ravsyre, og fremgangsmåde til fremstilling af ravsyre ved anvendelse af samme
WO2010112358A3 (de) Verfahren zur beschichtung einer oberfläche eines bauteils
WO2012163678A3 (de) Verfahren zur herstellung geschäumter tapeten
TW201129652A (en) Novel use of lipolytic enzyme for formation of anti-fingerprint coating, method of forming anti-fingerprint coating, substrate comprising the anti-fingerprint coating formed by the method, and product comprising the substrate
MX2010010053A (es) Granulos.
WO2010029331A3 (en) Colour forming composition
AR053143A1 (es) Metodo para preparar un sustrato revestido y sustratos obtenidos
WO2010022132A3 (en) Biocompatible coatings, and methods of making and using the same
WO2008139136A3 (en) Sensor coating
IN2013DN02545A (de)
TW200631791A (en) Self-adhesive laminate
CL2008002551A1 (es) Aducto amina-funcional; composicion curable, multicomponentes ; sustrato recubierto con dicha composicion; y procedimiento para proveer un recubrimiento a un sustrato
JP2009007185A5 (de)
WO2017123381A3 (en) Antifog coating composition and method of making thereof
WO2008092649A3 (de) Farbige markierung und beschriftung mittels energiereicher strahlung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application